Equillium Inc. Files DEFA14A Proxy Materials
Ticker: EQ · Form: DEFA14A · Filed: Apr 15, 2026
Sentiment: neutral
Topics: proxy-filing, sec-filing, pharmaceutical
Related Tickers: EQIL
TL;DR
EQIL filed proxy docs 4/15/26 - shareholders vote soon.
AI Summary
Equillium, Inc. filed a DEFA14A on April 15, 2026, related to additional definitive proxy soliciting materials. The filing includes various documents and graphics, with the company's principal office located in La Jolla, CA.
Why It Matters
This filing provides important information for shareholders regarding proxy solicitations, which can influence voting decisions on corporate matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently indicate significant new risks for the company.
Key Players & Entities
- Equillium, Inc. (company) — Filer of the DEFA14A
- 0001746466 (company) — CIK number for Equillium, Inc.
- 2026-04-15 (date) — Filing date of the DEFA14A
- LA JOLLA CA 92037 (location) — Mailing and Business Address of Equillium, Inc.
FAQ
What type of filing is this DEFA14A?
This DEFA14A filing is for additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-15 at 09:05:02.
What is Equillium, Inc.'s CIK number?
Equillium, Inc.'s CIK number is 0001746466.
Where is Equillium, Inc. located?
Equillium, Inc.'s business and mailing address is 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037.
What is the SIC code for Equillium, Inc.?
The SIC code for Equillium, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 15, 2026 regarding Equillium, Inc. (EQ).